Meticulous control of blood pressure is required in patients with hypertension to produce the
maximum reduction in clinical cardiovascular end points, especially in patients with …

Irbesartan | Drugs Skip to main content SpringerLink Account Menu Find a journal Publish
with us Track your research Search Cart 1.Home 2.Drugs 3.Article Irbesartan A Review of its …

This multicenter, prospective, open‐label, single‐arm study determined the efficacy and
safety of irbesartan/hydrochlorothiazide (HCTZ) fixed combinations in patients (n= 1005) …

In this review, we discuss the pharmacological and clinical properties of irbesartan, a
noncompetitive angiotensin II receptor type 1 antagonist, successfully used for more than a …

The long-term safety, tolerability, and antihypertensive effects of irbesartan/
hydrochlorothiazide (HCTZ) were assessed in hypertensive patients (seated diastolic blood …

Irbesartan interrupts the renin-angiotensin system via selective blockade of the angiotensin
II subtype 1 receptor; the latter being responsible for the pressor related effects of …

Severe hypertension is difficult to control. This prospective, randomized, double‐blind, active‐
controlled, multicenter trial compared efficacy and safety of once‐daily irbesartan …

Purpose. Current guideline recommendations for effective strategies to optimize the
treatment of patients with concomitant hypertension and type 2 diabetes mellitus are …

The elderly population is expanding rapidly throughout the world. Hypertension, heart
disease and other cardiovascular disorders are prevalent conditions among this age group …

Background Hypertension represents a major health problem, affecting more than one
billion adults worldwide. Irbesartan, an angiotensin II receptor blocker, is considered to be a …